Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Free Subscription


5 Cephalalgia
1 Headache

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles


  1. DODICK DW, Silberstein SD, Lipton RB, DeGryse RE, et al
    Early onset of effect of onabotulinumtoxinA for chronic migraine treatment: Analysis of PREEMPT data.
    Cephalalgia. 2019 May 21:333102418825382. doi: 10.1177/0333102418825382.
    PubMed     Text format     Abstract available

  2. KOGELMAN LJ, Falkenberg K, Halldorsson GH, Poulsen LU, et al
    Comparing migraine with and without aura to healthy controls using RNA sequencing.
    Cephalalgia. 2019 May 19:333102419851812. doi: 10.1177/0333102419851812.
    PubMed     Text format     Abstract available

  3. RUFF DD, Ford JH, Tockhorn-Heidenreich A, Sexson M, et al
    Efficacy of galcanezumab in patients with chronic migraine and a history of preventive treatment failure.
    Cephalalgia. 2019 May 19:333102419847957. doi: 10.1177/0333102419847957.
    PubMed     Text format     Abstract available

  4. HAANES KA, Labastida-Ramirez A, Blixt FW, Rubio-Beltran E, et al
    Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models.
    Cephalalgia. 2019 May 19:333102419851810. doi: 10.1177/0333102419851810.
    PubMed     Text format     Abstract available

  5. KHAN S, Amin FM, Fliedner FP, Christensen CE, et al
    Investigating macrophage-mediated inflammation in migraine using ultrasmall superparamagnetic iron oxide-enhanced 3T magnetic resonance imaging.
    Cephalalgia. 2019 May 19:333102419848122. doi: 10.1177/0333102419848122.
    PubMed     Text format     Abstract available


  6. ALAYDIN HC, Vuralli D, Keceli Y, Can E, et al
    Reduced Short-Latency Afferent Inhibition Indicates Impaired Sensorimotor Integrity During Migraine Attacks.
    Headache. 2019 May 20. doi: 10.1111/head.13554.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.